OVERVIEW

Community Practice Connections: 17th Annual International Congress on the Future of Breast Cancer is organized by Physicians' Education Resource, LLC and will be held from Sep 28, 2018 - Sep 28, 2019.

The target audience for this medical event is is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate. This CME Conference has been approved for a maximum of 1.5 Credits.

Description:
Community Practice Connections: 17th Annual International Congress on the Future of Breast Cancer® features a summary of clinical evidence guiding best practices in the treatment of patients with early-stage and advanced/metastatic breast cancer. The volume of emerging data and new drug approvals is exploding in breast cancer, creating new challenges for the clinician with regard to understanding how this information impacts treatment strategies for the various breast cancer subtypes.

This educational activity is designed to update you on the latest data that have changed practice, or have the potential to change practice, for hormone receptor?positive, HER2-positive, and triple-negative breast cancers. In addition, this activity will explore the evolving utility of gene expression assays for guiding treatment decision-making. Didactic summaries are accompanied by short video interviews with internationally recognized experts in the management of breast cancer. The video commentaries address decision points, challenges, and questions that you commonly face in community practice, and provide expert perspectives on the implications of recent data for optimizing outcomes for your patients with breast cancer.

Learning Objectives:
At the conclusion of this activity, you should be better prepared to:
• Individualize treatment planning for patients with breast cancer based on the appropriate use and interpretation of biomarker results and molecular or genomic assays
• Integrate recent clinical trial evidence into personalized treatment strategies for the management of patients with breast cancer
• Discuss emerging data regarding investigational approaches for managing breast cancer in the context of evolving treatment paradigms
• Identify variances in care and planned/ongoing clinical trials that are evaluating investigational approaches in breast cancer treatment settings